Scott Rottinghaus

Scott Rottinghaus

Company: Alexion Pharmaceuticals

Job title: Vice President & Head of Clinical Development, Hematology & Nephrology


Panel Discussion: Navigating Earlier Endpoint Development to Predict Clinical Outcome in Shorter Clinical Trials 11:30 am

Can we move towards harmonizing global regulatory endpoints? Non-invasive imaging, patient-reported outcomes, albuminuria and UACR: driving progress in elevating alternative outcome measures Can we incorporate patient reported outcomes in symptomatic kidney diseases?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.